文献速递神经肿瘤

叶酸受体过表达可在垂体腺瘤内镜经蝶手术中通过近红外成像实时可视化

Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.
PubMed 文献 · J Neurosurg · 2017-08-25

这项初步临床试验纳入19例成人垂体腺瘤患者,术前2-4小时输注叶酸类似物OTL38,术中用可见光与近红外光双模式4毫米内镜实时观察肿瘤与周围组织。15例可分析患者平均信号背景比(SBR)为1.9±0.70,高FRα表达者SBR为3.0±0.29(n=3),低表达者为1.6±0.43(n=12,p<0.05)。作者认为,对高FRα表达腺瘤,或可识别边界并预测术后MRI所见。

要点

  • 术前2-4小时输注OTL38后,术中近红外成像可实时显示垂体腺瘤,平均SBR为1.9±0.70。
  • 高FRα表达肿瘤SBR为3.0±0.29(n=3),低表达为1.6±0.43(n=12),差异有统计学意义(p<0.05)。
  • 3例免疫组化证实FRα过表达者,术中近红外成像分类肿瘤边界的敏感度和特异度均为100%。

核心结论

  • 术前注射OTL38后,术中可对垂体腺瘤及其边界进行近红外成像,肿瘤与背景对比在高FRα表达腺瘤中最明显。
  • 作者认为,对高FRα表达腺瘤,或可识别边界并预测术后MRI所见。

研究设计与样本

  • 这项新临床试验的初步分析纳入19例成人垂体腺瘤患者,术前2-4小时输注OTL38。
  • 术中使用4毫米可见光与近红外光双模式内镜实时观察肿瘤及边界,并记录不同内镜至蝶鞍距离下的信号背景比(SBR)。
  • 对所有标本行免疫组化分析评估FRα表达水平,将患者分为高表达或低表达;最终分析15例,4例因技术原因排除。

主要发现

  • 15例可分析患者中,术中近红外成像 delineated 全部主要肿瘤,平均SBR为1.9±0.70。
  • 腺瘤FRα表达水平与内镜至蝶鞍距离对荧光SBR有统计学显著影响;其他考虑因素包括腺瘤功能状态和OTL38注射后时间。
  • 高FRα表达肿瘤SBR为3.0±0.29(n=3),低表达肿瘤SBR为1.6±0.43(n=12),差异有统计学意义(p<0.05)。
  • 3例免疫组化证实FRα过表达者(2例无功能细胞腺瘤、1例临床沉默性促性腺激素腺瘤),术中近红外成像分类肿瘤边界的敏感度和特异度均为100%。
  • 上述3例中,术中残余荧光预测术后MRI结果完全一致。

临床怎么用

  • 作者认为,对高FRα表达腺瘤,术中近红外成像或可识别边界并预测术后MRI所见。

局限性

  • 本文为初步分析,最终仅15例可分析,4例因技术原因被排除。
  • 高FRα表达组仅3例,相关边界分类与MRI预测结果仅基于这3例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Pituitary adenomas account for approximately 10% of intracranial tumors and have an estimated prevalence of 15%-20% in the general US population. Resection is the primary treatment for pituitary adenomas, and the transsphenoidal approach remains the most common. The greatest challenge with pituitary adenomas is that 20% of patients develop tumor recurrence. Current approaches to reduce recurrence, such as intraoperative MRI, are costly, associated with high false-positive rates, and not recommended. Pituitary adenomas are known to overexpress folate receptor alpha (FRα), and it was hypothesized that OTL38, a folate analog conjugated to a near-infrared (NIR) fluorescent dye, could provide real-time intraoperative visual contrast of the tumor versus the surrounding nonneoplastic tissues. The preliminary results of this novel clinical trial are presented. METHODS Nineteen adult patients who presented with pituitary adenoma were enrolled. Patients were infused with OTL38 2-4 hours prior to surgery. A 4-mm endoscope with both visible and NIR light capabilities was used to visualize the pituitary adenoma and its margins in real time during surgery. The signal-to-background ratio (SBR) was recorded for each tumor and surrounding tissues at various endoscope-to-sella distances. Immunohistochemical analysis was performed to assess the FRα expression levels in all specimens and classify patients as having either high or low FRα expression. RESULTS Data from 15 patients (4 with null cell adenomas, 1 clinically silent gonadotroph, 1 totally silent somatotroph, 5 with a corticotroph, 3 with somatotrophs, and 1 somatocorticotroph) were analyzed in this preliminary analysis. Four patients were excluded for technical considerations. Intraoperative NIR imaging delineated the main tumors in all 15 patients with an average SBR of 1.9 ± 0.70. The FRα expression level of the adenomas and endoscope-to-sella distance had statistically significant impacts on the fluorescent SBRs. Additional considerations included adenoma functional status and time from OTL38 injection. SBRs were 3.0 ± 0.29 for tumors with high FRα expression (n = 3) and 1.6 ± 0.43 for tumors with low FRα expression (n = 12; p < 0.05). In 3 patients with immunohistochemistry-confirmed FRα overexpression (2 patients with null cell adenoma and 1 patient with clinically silent gonadotroph), intraoperative NIR imaging demonstrated perfect classification of the tumor margins with 100% sensitivity and 100% specificity. In addition, for these 3 patients, intraoperative residual fluorescence predicted postoperative MRI results with perfect concordance. CONCLUSIONS Pituitary adenomas and their margins can be intraoperatively visualized with the preoperative injection of OTL38, a folate analog conjugated to NIR dye. Tumor-to-background contrast is most pronounced in adenomas that overexpress FRα. Intraoperative SBR at the appropriate endoscope-to-sella distance can predict adenoma FRα expression status in real time. This work suggests that for adenomas with high FRα expression, it may be possible to identify margins and to predict postoperative MRI findings.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lee JYK, Cho SS, Zeh R, et al. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging. J Neurosurg. 2017. PMID: 28841122. doi:10.3171/2017.2.JNS163191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。